Elevated IDO1 activity and increased levels of kynurenine metabolites, which are activators of the AhR signaling pathway, are associated with inflammation and oxidative stress, processes implicated in the progression of DN (Yu et al., 2021). The gene discussed is IDO1; the disease is liver dysplastic nodule.